Citi healthcare analyst John Deakin-Bell says heavyweights ResMed, CSL and Ramsay Health Care have the most to gain when a COVID-19 vaccine is discovered and distributed.
Scientists are racing to find a safe and effective coronavirus vaccine and get it into production next year. On Sunday, CSL said it would start manufacturing preparatory elements for the leading University of Oxford/AstraZeneca vaccine this week, as work on the vaccine continues.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
